Article
Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.
Journal of clinical microbiology - 1 Sept 2013
Larrat Sylvie, Poveda Jean-Dominique, Coudret Camille, Fusillier Katia, Magnat Nelly, Signori-Schmuck Anne, Thibault Vincent, Morand Patrice
Abstract excerpt
For optimal antiviral therapy, the hepatitis C virus (HCV) genotype needs to be determined, as it remains a strong predictor of sustained viral response. In this study, we assessed the number of HCV genotyping results that could not be determined using the commercially available line probe assay (LiPA) (Versant hepatitis C virus genotype 2.0 assay) in a large international panel of samples from 9,874 HCV-positive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
